Prospective Interventional Study to Evaluate the Efficacy and Safety of Liposomal Amphotericin B as Prophylaxis of Fungal Infections in High-Risk Liver Transplant Recipients
- 1 November 2005
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (9) , 3965-3967
- https://doi.org/10.1016/j.transproceed.2005.10.043
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- PREEMPTIVE PROPHYLAXIS WITH A LIPID PREPARATION OF AMPHOTERICIN B FOR INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS REQUIRING RENAL REPLACEMENT THERAPY1Transplantation, 2001
- Targeted prophylaxis with amphotericin B lipid complex in liver transplantationLiver Transplantation, 2000
- AmBisome (Liposomal Amphotericin B): A Comparative ReviewThe Journal of Clinical Pharmacology, 1998
- Is Liposomal Amphotericin B (Ambisome) an Effective Prophylaxis of Mycotic Infections After Liver Transplantation?Transplantation Proceedings, 1998
- INVASIVE ASPERGILLOSIS IN LIVER TRANSPLANT RECIPIENTS IN THE 1990sTransplantation, 1997
- LIPOSOMAL AMPHOTERICIN B PREVENTS INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1995
- Fungal Infections in Solid-Organ TransplantationClinical Infectious Diseases, 1993